REA Group is an unstoppable ASX 200 share that has made investors rich. Over the past 15 years, the realestate.com.au ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Finding the right balance between safety and ...

The S&P 500 inched upward in New York trading, recovering from earlier losses as oil, gold, and silver prices increased amid ...

ResMed's (NYSE:RMD) stock up by 3.2% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be ...

The S&P 500 ended modestly higher. Oil rises 3pc, silver surges more than 6pc. The ASX will be closed on Monday for Australia ...

ResMed CEO Mick Farrell has become the first leader from the home care sector to chair the board of directors at AdvaMed, the trade association representing major medtech companies.

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

AdvaMed CEO Scott Whitaker and new AdvaMed Chair Mick Farrell discussed the MDUFA VI negotiations, FDA performance, tariffs ...

Our extensive research on the United States Remote Patient Monitoring (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, i ...

Based on Resmed’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.34 billion and a net profit of $348.54 million. In comparison, last year ...